Program increased guideline adherence for patients with STEMI, non-STEMI

November 2012
Cardiology Today;Nov2012, Vol. 15 Issue 11, p35
The article discusses research on the influence of Get with the Guidelines-Coronary Artery Disease program on adherence with guideline-based medical therapy for patients with STEMI and non-STEMI, referencing a study published in "Circulation: Cardiovascular Quality and Outcomes."


Related Articles

  • Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. Briel, Matthias; Ferreira-Gonzalez, Ignacio; You, John J.; Karanicolas, Paul J.; Akl, Elie A.; Ping Wu; Blechacz, Boris; Bassler, Dirk; Xinge Wei; Sharman, Asheer; Whitt, Irene; da Silva, Suzana Alves; Khalid, Zahira; Nordmann, Alain J.; Qi Zhou; Walter, Stephen D.; Vale, Noah; Bhatnagar, Neera; O'Regan, Christopher; Mills, Edward J. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/28/2009, p522 

    Objective To investigate the association between treatment induced change in high density lipoprotein cholesterol and total death, coronary heart disease death, and coronary heart disease events (coronary heart disease death and non-fatal myocardial infarction) adjusted for changes in low...

  • Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes. Young, Lawrence H.; Wackers, Frans J. Th.; Chyun, Deborah A.; Davey, Janice A.; Barrett, Eugene J.; Taillefer, Raymond; Heller, Gary V.; Iskandrian, Ami E.; Wittlin, Steven D.; Filipchuk, Neil; Ratner, Robert E.; Inzucchi, Silvio E. // JAMA: Journal of the American Medical Association;4/15/2009, Vol. 301 Issue 15, p1547 

    The article reports on the results of research which was conducted in an effort to assess whether routine screening for coronary artery disease identifies patients with type 2 diabetes as being at high cardiac risk and whether it effects their cardiac outcomes. Researchers used a randomized...

  • Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia. van Ramshorst, Jan; Bax, Jeroen J.; Beeres, Saskia L. M. A.; Dibbets-Schneider, Petra; Roes, Stijntje D.; Stokkel, Marcel P. M.; de Roos, ALbert; Fibbe, Willem E.; Zwaginga, Jaap J.; Boersma, Eric; Schalij, Martin J.; Atsma, Douwe E. // JAMA: Journal of the American Medical Association;5/20/2009, Vol. 301 Issue 19, p1997 

    The article reports on the results of research which was conducted in an effort to investigate the effect of intramyocardial bone marrow cell injection on myocardial perfusion and left ventricular function in patients with chronic myocardial ischemia. Researchers used a randomized, double-blind,...

  • Socioeconomic Status Correlates with the Prevalence of Advanced Coronary Artery Disease in the United States. Bashinskaya, Bronislava; Nahed, Brian V.; Walcott, Brian P.; Coumans, Jean-Valery C. E.; Onuma, Oyere K.; Biondi-Zoccai, Giuseppe // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Background: Increasingly studies have identified socioeconomic factors adversely affecting healthcare outcomes for a multitude of diseases. To date, however, there has not been a study correlating socioeconomic details from nationwide databases on the prevalence of advanced coronary artery...

  • RETRACTION: Prescribing of β-adrenoceptor antagonists in asthma: an observational study. Morales, Daniel R. // Thorax;Mar2011, Vol. 66 Issue 3, p269 

    The article reports on the retraction of the article "Prescribing of b-Adrenoceptor Antagonists in Asthma: An Observational Study" by D. R. Morales et al.

  • MOS.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1495 

    A definition of the medical acronym "MOS," which refers to medical outcomes study, is presented.

  • Authors' response: surgical outcomes after epiretinal membrane peeling combined with cataract surgery. Yiu, Glenn; Marra, Kyle V.; Arroyo, Jorge G. // British Journal of Ophthalmology;Dec2013, Vol. 97 Issue 12, p1609 

    Glenn Yiu, Kyle V. Marra and Jorge G. Arroyo respond to a letter to the editor submitted in response to their previous article, which was concerned with surgical outcomes after epiretinal membrane peeling combined with cataract surgery.

  • Longitudinal change of prebronchodilator spirometric obstruction. Mohamed Hoesein, Firdaus A. A.; Zanen, Pieter; Lammers, Jan-Willem J.; Probst-Hensch, Nicole M.; Curjuric, Ivan; Bridevaux, Pierre-Olivier; Künzli, Nino; Schindler, Christian; Rochat, Thierry // Thorax;Mar2011, Vol. 66 Issue 3, p267 

    Two letters to the editor are presented in response to the article "Longitudinal Change of Prebronchodilator Spirometric Obstruction and Health Outcomes: Results From the SAPALDIA Cohort" by N. M. Probst-Hens et al.

  • Biosimilar erythropoietin uptake not linked to price.  // PharmacoEconomics & Outcomes News;Jul2014, Vol. 706 Issue 1, p7 

    The article discusses research on the link between the uptake of erythropoietin biosimilars and price, referencing a study led by F. Bocquet, presented at the 19th Annual International Meeting of the International Society for PharmacoEconomics and Outcomes Research (ISPOR) in May 2014.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics